Molecular determinant of clinical response to ONC201, an inhibitor of dopamine receptor 2 (DRD2) signaling, in glioblastoma patient.

Jie Li, Jun Ma, Yuyu He, Varun Vijay Prabhu, Joshua Allen, Clark C Chen

Research output: Contribution to conferencePoster

Abstract

Jie Li, Jun Ma, Yuyu He, Varun Vijay Prabhu, Joshua Allen, Clark Chen. Molecular determinant of clinical response to ONC201, an inhibitor of dopamine receptor 2 (DRD2) signaling, in glioblastoma patient. — 23rd Annual Meeting of the Society for Neuro-Oncology. (Physical poster. Neuro-Oncology 20(suppl_6):vi90-vi90. November 15-18, 2018.)
Original languageEnglish (US)
StatePublished - 2018

Fingerprint Dive into the research topics of 'Molecular determinant of clinical response to ONC201, an inhibitor of dopamine receptor 2 (DRD2) signaling, in glioblastoma patient.'. Together they form a unique fingerprint.

Cite this